TapImmune to Present at 29th Annual Piper Jaffray Healthcare Conference

JACKSONVILLE, Florida, November 21, 2017 / TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced its President and CEO, Peter Hoang, will present at the 29th Annual Piper Jaffray Healthcare Conference held November 28-29, 2017 in New York, NY.

TapImmune Event Details:

Date: Wednesday, November 29, 2017
Time: 3:50 p.m. (Eastern Time)
Location: Lotte New York Palace Hotel, New York, NY

An audio webcast will be accessible via the News and Events section of the TapImmune website https://markertherapeutics.com/event/. An archive of the audio will remain available for 90 days following the presentation.